Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
4.020
-0.110 (-2.66%)
Apr 29, 2026, 2:13 PM EDT - Market open

Whitehawk Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Market Capitalization
1901147850313505
Upgrade
Market Cap Growth
147.28%46.66%56.96%-84.17%-37.97%-
Upgrade
Enterprise Value
48-4916-68132344
Upgrade
Last Close Price
4.132.423.152.0212.8324.15
Upgrade
PS Ratio
27.0515.962.992.0320.57450.53
Upgrade
PB Ratio
1.430.841.480.471.983.70
Upgrade
P/TBV Ratio
1.420.841.480.471.983.81
Upgrade
EV/Sales Ratio
6.66-0.62-8.66306.99
Upgrade
Debt / Equity Ratio
--0.020.010.010.00
Upgrade
Net Debt / Equity Ratio
-1.07-1.07-0.88-1.02-1.08-1.09
Upgrade
Net Debt / EBITDA Ratio
1.271.270.721.502.914.01
Upgrade
Net Debt / FCF Ratio
1.491.490.761.693.416.60
Upgrade
Asset Turnover
0.070.070.260.150.090.01
Upgrade
Inventory Turnover
--9.2112.49--
Upgrade
Quick Ratio
10.0410.043.114.339.269.76
Upgrade
Current Ratio
10.2610.263.594.729.569.90
Upgrade
Return on Equity (ROE)
-21.82%-21.82%-80.79%-49.90%-41.06%-177.60%
Upgrade
Return on Assets (ROA)
-64.66%-64.66%-39.96%-28.39%-21.54%-26.21%
Upgrade
Return on Capital Employed (ROCE)
-83.90%-83.90%-121.70%-67.80%-35.60%-26.00%
Upgrade
Earnings Yield
-10.66%-18.06%-81.90%-132.75%-19.33%-21.82%
Upgrade
FCF Yield
-50.70%-85.91%-78.71%-128.45%-16.00%-4.45%
Upgrade
Buyback Yield / Dilution
-128.96%-128.96%-0.42%-19.58%-152.27%-250.99%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.